William Lewis Insmed Inc (INSM) insider trading activity

William Lewis is Chair and CEO of INSMED Inc. Currently has a direct ownership of 379,534 shares of INSM, which is worth approximately $29.8 Million. The most recent transaction as insider was on Jan 15, 2025, when has been sold 31,805 shares (Common Stock) at a price of $70.25 per share, resulting in proceeds of $2,234,301. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 380K

1.2% 3M change

4.37% 12M change

Total Value Held $29.8 Million

William Lewis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 15 2025	SELL Open market or private sale	$2,234,301 $70.25 p/Share	31,805 Reduced 7.73%	379,534 Common Stock
Jan 15 2025	BUY Exercise of conversion of derivative security	$426,750 $22.76 p/Share	18,750 Added 4.36%	411,339 Common Stock
Jan 10 2025	SELL Open market or private sale	$188,686 $63.36 p/Share	2,978 Reduced 0.75%	392,589 Common Stock
Jan 08 2025	SELL Open market or private sale	$263,774 $65.96 p/Share	3,999 Reduced 1.06%	372,743 Common Stock
Jan 08 2025	BUY Grant, award, or other acquisition	-	22,824 Added 5.46%	395,567 Common Stock
Jan 07 2025	SELL Open market or private sale	$542,552 $66.02 p/Share	8,218 Reduced 2.13%	376,742 Common Stock
Jan 02 2025	SELL Open market or private sale	$1,309,500 $69.84 p/Share	18,750 Reduced 4.64%	384,960 Common Stock
Jan 02 2025	BUY Exercise of conversion of derivative security	$426,750 $22.76 p/Share	18,750 Added 4.44%	403,710 Common Stock
Dec 19 2024	SELL Open market or private sale	$1,314,000 $70.08 p/Share	18,750 Reduced 4.64%	384,960 Common Stock
Dec 19 2024	BUY Exercise of conversion of derivative security	$426,750 $22.76 p/Share	18,750 Added 4.44%	403,710 Common Stock
Dec 12 2024	SELL Open market or private sale	$1,377,374 $73.46 p/Share	18,750 Reduced 4.64%	384,960 Common Stock
Dec 12 2024	BUY Exercise of conversion of derivative security	$426,750 $22.76 p/Share	18,750 Added 4.44%	403,710 Common Stock
May 14 2024	SELL Open market or private sale	$566,492 $25.52 p/Share	22,198 Reduced 5.46%	384,125 Common Stock
May 13 2024	BUY Grant, award, or other acquisition	-	42,707 Added 9.51%	406,323 Common Stock
Jan 09 2024	SELL Open market or private sale	$283,954 $28.72 p/Share	9,887 Reduced 2.65%	363,651 Common Stock
Jan 08 2024	SELL Open market or private sale	$1,331,040 $29.5 p/Share	45,120 Reduced 10.78%	373,538 Common Stock
Jan 08 2024	BUY Exercise of conversion of derivative security	$924,508 $20.49 p/Share	45,120 Added 10.28%	393,707 Common Stock
Jan 05 2024	SELL Open market or private sale	$204,205 $29.26 p/Share	6,979 Reduced 1.83%	373,538 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	37,869 Added 9.05%	380,517 Common Stock
May 17 2023	SELL Open market or private sale	$128,633 $18.12 p/Share	7,099 Reduced 2.04%	341,345 Common Stock
May 16 2023	SELL Open market or private sale	$68,374 $18.41 p/Share	3,714 Reduced 1.05%	348,444 Common Stock
May 15 2023	SELL Open market or private sale	$116,303 $19.23 p/Share	6,048 Reduced 1.69%	352,158 Common Stock
May 11 2023	BUY Grant, award, or other acquisition	-	93,139 Added 20.64%	358,206 Common Stock
Jan 10 2023	SELL Open market or private sale	$125,892 $18.0 p/Share	6,994 Reduced 2.57%	265,067 Common Stock
Jan 05 2023	SELL Open market or private sale	$138,758 $19.8 p/Share	7,008 Reduced 2.73%	249,708 Common Stock

Also insider at

NAMS

NewAmsterdam Pharma Co N.V.

William Lewis

Chair and CEO

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSM shares.

Notify only if

Value

Insider Trading

Get notified when an Insmed Inc insider buys or sells INSM shares.

Notify only if

Operation

Value

Type

News

Receive news related to INSMED Inc

Track Activities on INSM

Account